tiprankstipranks
Trending News
More News >
Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
US Market

Pharmagreen Biotech (PHBI) Income Statement

Compare
60 Followers

Pharmagreen Biotech Income Statement

Last quarter (Q3 2025), Pharmagreen Biotech's total revenue was $335.00, a decrease of -45.53% from the same quarter last year. In Q3, Pharmagreen Biotech's net income was $45.58K. See Pharmagreen Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Dec 23Dec 22Dec 21Sep 20
Total Revenue
$ 3.41K$ 3.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.74K$ -6.45K$ 0.00$ -435.00K$ -435.00K
Operating Expenses
$ 249.92K$ 467.56K$ 1.07M$ 752.73K$ 485.75K
Depreciation and Amortization
$ 248.18K$ 474.01K$ 1.07M$ 0.00$ 485.75K
EBITDA
$ -971.18K$ 26.36K$ 194.27K$ -3.76M$ -677.00K
Operating Income
$ -248.00K$ -474.00K$ -1.07M$ -753.00K$ -677.00K
Other Income/Expenses
$ -756.00K$ -94.79K$ 194.24K$ -3.78M$ -2.00M
Pretax Income
$ -1.00M$ -569.00K$ -876.00K$ -4.53M$ -2.48M
Net Income
$ -1.00M$ -569.00K$ -875.00K$ -4.53M$ -2.44M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ -0.02$ -0.03
Diluted EPS
$ 0.00$ 0.00$ 0.00$ -0.02$ -0.03
Weighted Average Shares Outstanding
659.49M 466.59M 403.73M 293.71M 82.07M
Weighted Average Shares Outstanding (Diluted)
659.37M 466.53M 403.73M 293.71M 82.07M
Currency in USD

Pharmagreen Biotech Earnings and Revenue History